Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 248-372-5 | CAS number: 27253-30-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
No acute toxicity studies with lithium neodecanoate are available, thus the acute toxicity will be addressed with existing data on the dissociation products lithium and neodecanoic acid. The LD50 value for the moiety neodecanoic acid was shown to be greater than 2000 mg/kg bw in experimental testing. Three studies with the moiety lithium are available. All studies available were used in a weight of evidence approach and the oral LD50 value was calculated to be about 525 mg/kg bw corresponding to 98.65 mg Li/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
No acute toxicity studies with lithium neodecanoate are available, thus the acute toxicity will be addressed with existing data on the dissociation products lithium and neodecanoic acid.
Lithium
Acute oral toxicity
According to handbook data, the LD50 of lithium carbonate is 723 +/- 38 mg/kg bw after oral administration to female rats and 640 +/- 30 mg/kg bw to male rats and according to a review article, the LD50 of lithium carbonate is 525 mg/kg bw after oral administration to rats. Thus, even when considering the lower study result, the substance has to be classified as cat 4, H302 (harmful if swallowed) according to Regulation (EC) No 1272/2008.
Acute inhalation toxicity
It could be shown in two inhalation studies, performed with the maximal attainable concentrations of 0.80 mg/L that the LC50 is higher than 0.80 mg/L and estimated to be higher than 2 mg/L. In conclusion, the LC50 (inhalation, rat) of lithium carbonate is equal or higher than 2.0 mg/L and the substance is therefore not to be classified according to Regulation (EC) No 1272/2008 (CLP).
Acute dermal toxicity
A LD50 value of greater than 3000 mg/kg bw and LD0 value of 2000 mg/kg bw were determined in an acute dermal study that examined lithium carbonate in doses of 2000 mg/kg bw and 3000 mg/kg bw. In two additional acute dermal studies performed as limit tests a LD50 value of > 2000 mg/kg bw was determined. Thus, in conclusion, the LD50 (dermal rat) of lithium carbonate is greater than 3000 mg/kg bw and the substance is not to be classified according to Regulation (EC) No 1272/2008 (CLP).
Neodecanoic acid
Neodecanoic acid has a low potential for toxicity via the oral, inhalation, and dermal routes.
Acute oral toxicity
Male and female rats were gavaged with neodecanoic acid at concentrations of 1, 1.5, 2, 3, or 4 ml/kg to assess acute oral toxicity. All animals that died during the study did so within 3 days of exposure. Signs of toxicity included lethargy, hypothermia, piloerection, dyspnea, and ataxia. Based on these results, it is concluded that the LD50 is approximately 2.27 ml/kg (2066 mg/kg).
Lithium neodecanoate
The moiety neodecanoic acid has not shown signs of acute oral toxicity in experimental testing (LD50 > 2000mg/kg). Three studies with the moiety lithium are available. All studies available were used in a weight of evidence approach and the oral LD50 value for lithium carbonate was calculated to be about 525 mg/kg bw.
Based on the assumption that lithium is the moiety of concern and responsible for adverse effects observed, an LD50 value for lithium of about 98.65 mg/kg bw could be calculated based on the molecular weight.
Under the assumption that the moieties of lithium neodecanoic show their toxicological profile individually upon dissolution, the acute oral toxicity of lithium neodecanoate can be calculated using the equation given in regulation (EC) 1272/2008, Annex I, Section 3.1.3.6.1.
The calculated oral LD50 for lithium neodecanoate is > 2000mg/kg based on stochiometric lithium content of 4.9 %, hence the substance is not to be classified according to regulation (EC) 1272/2008 for acute oral toxicity.
The calculated oral LD50 for lithium neodecanoate is 300 < LD50 <= 2000 based on the highest lithium content of 6.4 % (overbased product), thus the substance is classified according to regulation (EC) 1272/2008 for acute oral toxicity category 4 (H302: Harmful if swallowed). Due to the differences in classification and labelling for lithium neodecanoate based on the lithium content, two GHS profiles were created. However, the risk assessment was performed by using the worst-case scenario and assuming the highest lithium content of 6.4 % (overbased prorduct).
The calculated dermal LD50 for lithium neodecanoate is > 2000mg/kg, hence the substance is not to be classified according to regulation (EC) 1272/2008 for acute dermal toxicity.
For further information on the toxicity of the assessment entities, please refer to the relevant sections in the IUCLID and CSR.
Justification for classification or non-classification
The calculated oral LD50 for lithium neodecanoate is > 2000mg/kg based on stochiometric lithium content of 4.9 %, hence the substance is not to be classified according to regulation (EC) 1272/2008 for acute oral toxicity.
The calculated oral LD50 for lithium neodecanoate is 300 < LD50 <= 2000 based on the highest lithium content of 6.4 % (overbased product), thus the substance is classified according to regulation (EC) 1272/2008 for acute oral toxicity category 4 (H302: Harmful if swallowed). Due to the differences in classification and labelling for lithium neodecanoate based on the lithium content, two GHS profiles were created. However, the risk assessment was performed by using the worst-case scenario and assuming the highest lithium content of 6.4 % (overbased prorduct).
The calculated dermal LD50 for lithium neodecanoate is > 2000mg/kg, hence the substance is not to be classified according to regulation (EC) 1272/2008 for acute dermal toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.